Myriad Genetics Blog

Myriad Genetics is passionate about helping people lead healthier lives through the power of genetic insights. Our contribution comes in the…

It’s October, and you know what that means: falling leaves, Halloween, and — of most importance — Breast Cancer Awareness Month!…

Today we get back to our employee profile series, and we’re chatting with Heidi Gorringe, Senior Manager of the Medical Information…

By John Ryan, Senior Vice President of Lab Operations On September 11th, 2001 the lives of all Americans were forever changed.…

Our mission of advancing health and well-being for all is meaningful. We’ve accomplished a lot so far this year, and I…

The Myriad Genetics team, together with leading healthcare collaborators, has been hard at work to expand access to reliable genetic testing…

As we continue to get to know the people who help make Myriad Genetics a leader in genetic testing, today we…

At Myriad Genetics, we’re proud to deliver clinically actionable genetic information in the areas of oncology, women’s health, and mental health.…

We are already looking forward to one of the biggest cancer-focused conferences of the year: the annual meeting of the American…

Leading the Way to the Future of Genetic Testing and Precision Medicine Thirty years ago, Myriad Genetics played a pivotal role…

This week is Medical Laboratory Professionals Week, and that means the Myriad Genetics team is celebrating! Now in its 45th year, “Lab Week,” as it’s…

Since joining Myriad Genetics two decades ago, I’ve had five different roles across various departments––and the company has nurtured my dream…

You hear a lot about certain types of cancer. In fact, you can probably name some famous people who have had…

Here at Myriad Genetics, we take every opportunity to rejoice in our team’s diversity. During Black History Month, we’ve been doing…

In honor of National Cancer Prevention Month, we wanted to raise awareness of some actions you can take right now to…

A new, peer-reviewed paper published in JCO Precision Oncology shows the clear value of incorporating genetic data with existing clinical models…

It was 6 years ago that I learned I was BRCA2+. The Myriad MyRisk™ test was encouraged by my OB/GYN based…

At the December meeting of its Board of Directors, Myriad Genetics recognized the meaningful contributions of three retiring board members —…

Today, on Genetic Counselors Awareness Day, we at Myriad Genetics want to recognize and show appreciation to all the genetic counselors who dedicate themselves…

October is here and it is breast cancer awareness month. I celebrate this month like some people celebrate Halloween or Christmas.…

By Dr. James Goldberg, M.D.   “Is my baby healthy?” was one of the most asked questions I received when I was…

We are heartbroken over the systemic discrimination and racism that have persisted in this nation for too long. We have been…

March 16, 2020 Dear Customer, At Myriad, we are actively monitoring the COVID-19/Coronavirus situation and have implemented a business continuity plan…

Myriad Genetics has been in business for almost 30 years and we are a global leader in precision medicine.  Click on…

Fall slump. The winter blahs. Is it almost spring? Weather can have an impact on our daily mood and feelings. For…

Pancreatic cancer is the third leading cause of death due to cancer.1 Approximately 56,500 people, or 1 in 64, will be diagnosed…

This month, we are striving to bring awareness to spinal muscular atrophy (SMA), a serious inherited condition caused by changes in the SMN1 gene,…

July is Minority Mental Health Awareness Month.  It is estimated that 1 in 5 minorities struggle with depression, which is the…

Transforming Patients’ Lives with Pioneering Genetic Tests At Myriad, we are proud of our long-standing commitment to fighting cancer, which continues…

May is Mental Health Awareness Month 2019 and marks the 70th anniversary of this important event.  Its purpose is to increase…

Colon cancer is the second-leading cause of cancer death in the United States. According to the American Cancer Society, one in…

When it comes to cancer, it is often said that “an ounce of cancer prevention is worth a ton of cancer…

Myriad Genetics has been in business for more than 27 years and we are a global leader in personalized medicine.  Click…

Counsyl, Inc. has combined with Myriad Genetics’ Preventive Care business unit to form Myriad Women’s Health, Inc., a premier genetic screening…

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can…

According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime.  In…

September is Prostate Cancer Awareness Month. According the American Cancer Society, more than 165,000 men will be diagnosed with prostate cancer…

The biomedical innovation now happening in the molecular diagnostics industry is making it possible for clinicians to answer their patients’ four…

Mental Health Month, Depression and GeneSight®    The GeneSight® genetic test has produced exciting news for patients diagnosed with depression.  A landmark…

In hereditary colon cancer, knowledge is power!  During the month of March, Myriad Genetics is demonstrating a strong commitment to preventing hereditary colon…

The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic…

It is estimated that 19 million people suffer from “year round” depression. If every American with depression lived in one state…

Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29…

When diagnosed with prostate cancer, genetic precision can guide decisions between patients and their doctors. Click below to learn more and…

Nothing is more personal than an individual’s DNA fingerprint.  At Myriad Genetics, we honor our legal and ethical responsibility to protect…

Myriad Genetics was proud to support Project BioEYES and help deliver STEM (science, technology, engineering, and mathematics) education to K-12 students…

June is Men’s Health Month and it’s important to help generate awareness on education for early detection of Men’s health issues, such as…

“I just could not get out of bed, no matter how hard I tried.”   Years ago, before taking the GeneSight…

What is GeneSight? GeneSight Psychotropic is a laboratory developed genetic test that looks at many of the genes involved when your…

Extract your own DNA at home! DNA, or Deoxyribonucleic acid, is the hereditary information in humans and most other plants and…

Improving precision matters in prostate cancer    Understanding the risk of prostate cancer is very important for men ages 40 and…

The strong culture of Myriad is a critical component of our company’s success.  Today, we are launching an Employee Spotlight!  It’s…

Introducing a More Accurate Breast Cancer Diagnostic Test We are very excited to announce the launch of EndoPredict in the U.S.! This…

March is Colon Cancer Awareness Month and it’s a good time to learn about hereditary colon cancer and how to lower…

Understanding your risk for hereditary cancer is an important step in preventing cancer. Myriad Genetics has put together this new infographic…

A variety of fine English foods With Victoria Sponge Cake, clotted crème, and Branston pickle on their lips a small group…

EVP for Emerging Products Patrick Burke notes that our research and development model requires us to rely on collaborations with academics…

Dr. Johnathan Lancaster talks about Myriad’s policies on patient privacy and access to their personal genetic test results. “Myriad believes that…

CEO Mark Capone talks about Myriad’s 25-year history and our pioneering work in the molecular diagnostics industry, as well as his…

Six years ago, my doctor told me I had prostate cancer, and the news literally brought me to my knees. To…

Our EVP of Human Resources Jayne Hart talks about why Myriad is such a special and unique place to work and…

VP of Medical Services Susan Manley explains what genetic mutations are and how testing can definitively determine whether or not a…

Dr. Johnathan Lancaster describes advances in the field of testing for hereditary endometrial and colon cancers, which are some of the…

VP of Medical Services Susan Manley talks about the emphasis Myriad places on test accuracy and the steps we take to…

CEO Mark Capone talks about the primary challenges facing the molecular diagnostics industry and Myriad’s role as an industry leader in…

CEO Mark Capone describes Myriad’s efforts to ensure that patients have access to our tests because we understand how the tests…

CEO Mark Capone explains what personalized medicine is and the role of genetics in tailoring and improving treatments for individual patients.…

Myriad CEO Mark Capone notes that the current healthcare system in the U.S. is one of the most effective in the…

CEO Mark Capone talks about the importance we place on research collaborations and the role molecular diagnostics play in tailoring treatments…

CEO Mark Capone describes Myriad’s innovative role in the development of molecular diagnostics. “We actually invented the research- based, education-centric business…

CEO Mark Capone tells the story of one patient and how genetic testing might have saved her life, as well as…

CEO Mark Capone describes the unique Myriad culture and what the “DNA of a Myriadian” means to us. “We recognize that…

CEO Mark Capone looks at the pioneering role Myriad is playing a as we enter the golden era of molecular diagnostics…

CEO Mark Capone talks about our mission, which is to answer patients’ four most pressing questions in six medical specialties.

CEO Mark Capone describes the Myriad Vision and what it means to us. “We want to be the trusted advisor transforming…

Myriadians are passionate about saving and improving the lives of patients worldwide with our breakthrough molecular diagnostic tests. That commitment extends…

CEO Mark Capone talks about why patients and physicians choose Myriad when decisions matter most. “We recognize that patients are going…

Myriad has changed a lot over the past 20 years. We’ve gone from being a single product company in just the…

At Myriad, corporate responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all…

On August 13, 2015, Medicare approved coverage of the Prolaris® test for men diagnosed with low-risk and very low-risk prostate cancer.…

It’s been wonderful to watch the evolution of medicine over the course of my career. Twenty years ago, when I finished…

Looking back, my journey with cancer really began when I was 40, a year after my paternal grandmother passed away. That…

KNOW THE FACTS Knowing the facts is the first step in the reduction, prevention and early detection of skin cancer and…

March is Colon Cancer Awareness Month. It’s a good time to learn more about hereditary colon cancer and how to lower…

Myriad has led the industry in genetic testing for hereditary breast and ovarian cancer since the launch of BRACAnalysis® in 1996.…

All of us at Myriad – from the executives and researchers, to the sales and customer service representatives – work hard…

I have always felt lucky. My husband and I met in college when I was just 18 and were married shortly…

We are honored by the ongoing recognition of Forbes Magazine for the outstanding business growth that our employees have achieved as…

Our legacy is that of one of the first genomic companies in history. We pioneered the first commercial molecular diagnostic test…

The evening of September 19th was a night filled with an abundance of fun and meaning in the Big Easy. A…

I never had a chance to meet my paternal grandfather, Eric. He was a handsome truck driver just like my Dad.…

At Myriad, we regularly reach out to our customers in the medical and scientific communities as part of our ongoing process…

As the first Myriad employee, I know from experience that social responsibility has been ingrained in the DNA of our culture…

Inherited genetic variation is a fundamental of biology and both drives and reflects the process of evolution. Layered upon inherited variation…

I recently had the honor of meeting Joe (his name has been changed to protect his privacy), a 70-year-old man who…

There are moments in every life that have staying power. You’ll always know where you were when “it” happened. Sometimes these…

I think it is so important for me to tell my story — mostly because it is probably similar to other…

I have always been an optimist, a glass half-full type of person. So when I found a lump in my breast…

As I looked at the pathology report bearing my name and the words “poorly differentiated ductal carcinoma of the left breast,”…

In April 2010, I tested positive for the BRCA2 mutation. I am a mammogram technologist so I have seen firsthand the…

Many families are very private about things like cancer and other medical conditions. They just don’t talk about these things. But…

My wife, Heather, was BRCA positive. She passed away this July 4th after a three-year battle with ovarian cancer, leaving behind…

There’s a funny scene in the 1985 film, St. Elmo’s Fire, when Billy (Rob Lowe) is having dinner at the family…

After working at Myriad Genetics for more than 20 years, I have been fortunate to see many examples of how our…

  To date Myriadians across the country have successfully walked, fundraised and educated colon, ovarian, and breast cancer survivors and caregivers…

This past September Team Myriad joined more than 500 women for Bright Pink’s annual health and wellness event, FabFest 2013. The…

  October is Breast Cancer Awareness Month and once again Myriad Genetics, Inc. is proud to be joining efforts with the…

Break Out the Teal! September is Ovarian Cancer Awareness Month! According to the National Cancer Institute’s website 22,240 women will be…

Data recently presented by Myriad Genetics’ prostate cancer prognostic test Prolaris is getting healthcare professionals and patients interested in learning more…

MELANOMA MONDAY All Year Skin cancer is one of the most common form of all cancers. Though accounting for less than…

MELANOMA MONDAY Know How to Protect Yourself Skin cancer is one of the most common form of all cancers. Though accounting…

MELANOMA MONDAY Know Your Skin Skin cancer is one of the most common form of all cancers. Though accounting for less…

Not many of us can look at a genetic code and be inspired to create artwork from it. For most people…

MELANOMA MONDAY Know Your Risk Skin cancer is one of the most common form of all cancers. Though accounting for less…

Today, May 8th 2013 marks the very first World Ovarian Cancer Day. Today several organizations from around the world will join…

MELANOMA MONDAY Know The Facts Skin cancer is one of the most common form of all cancers. Though accounting for less…

We’re in the business of saving lives.  That’s what really matters to me, and to the very bright people who work…

(you can also view Jill’s video HERE) My name is Jill and I am a two-time cancer survivor—I was diagnosed with…

Saturday, March 9, 2013 was a chilly morning on the coast of southern California but OH WHAT A DAY! Twenty eight…

SALT LAKE CITY, March 5, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a study published in the Journal…

“When I was in high school, my mom was diagnosed with breast cancer at age 42. She had a lumpectomy, chemo,…

As the shortest month of the year draws to a close, it’s important to remember that it takes longer than 28…

February 6, 2013 RE: COLARIS® and COLARIS AP® MYH Enhancements Myriad Genetic Laboratories, Inc. is pleased to announce enhancements to our…

For the past few years, Myriad has partnered with NSGC to host three genetic counseling student interns during the summer. The…

For the past few years, Myriad has partnered with NSGC to host three genetic counseling student interns during the summer. The…

For the past few years, Myriad has partnered with NSGC to host three genetic counseling student interns during the summer. The…

Winter can wreak havoc on your skin.  The extreme changes from the outside cold to inside re-circulated heated air depletes skin…

Adam A. Ofer, MD, is a board-certified Ob/Gyn and the Director of Gynecology at the Norwalk Hospital in Connecticut.  His focus…

Julie Eggington, PhD Variant Specialist Team Fun Fact: Julie is originally from Australia   Julie has managed the variant specialist team…

There are limited recommendations on this topic.1 The following summarizes the literature, however, a clinician’s judgment will also be based on…

The holidays are known as a time for giving and Myriad proudly helped bring that giving spirit to the Cancer Wellness…

SALT LAKE CITY, Dec. 17, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (MYGN) announced today that Peter D. Meldrum, President and…

Myriad RBM to Perform Protein Biomarker Discovery on Over 8,000 Serum Samples From Patients With Pre-Diabetes or Type 2 Diabetes SALT…

Dreaming of a White Christmas?  Better get out the sunscreen and shades! Being smart about the UV rating and your exposure…

This past week Myriad Genetic Laboratories had the opportunity to present 2 posters at the Society for Urologic Oncologists that was…

SALT LAKE CITY, Nov. 28, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled “CCP Score Significantly Predicts PSA…

It’s that time of year again! We want to remind you that during all of these family holiday gatherings it is…

The Great Prostate Cancer Challenge (GPCC) is the premier men’s health race and event series in America.  It is an exciting…

In the last weeks, Myriad Genetics has been conducting alumni speaker trainings for its front-line healthcare professional and mid-level providers. These…

Myriad is excited to announce the launch of the online Hereditary Cancer Quiz. This quiz was designed for the general public…

The Preventive Care marketing team had the opportunity to attend the ACOG District II show in New York a few weeks…

The National Ovarian Cancer Coalition (NOCC)’s 2012 Conference in Las Vegas, Nevada was held November 8th through 10th. Survivors, caregivers, healthcare…

Know Your Skin Hereditary melanoma is just one risk factor for this rare but deadly form of skin cancer.  Knowing your…

Today’s Myridian Monday spotlight is on John Ryan, the Senior Director of Operations and an employee of Myriad for over 12 years.…

If you notice more people walking around with mustaches this month don’t be surprised! In the past 9 years the “movember” movement has…

William J. Harb, MD, FACS, FASCRS, is a board-certified colorectal surgeon, specializing in the treatment of diseases of the colon and…

This fall Myriad participated in eleven National Ovarian Cancer Coalition Walks to Break the Silence on Ovarian Cancer with just one…

It’s important to always make sure that you have a little fun sometimes! Today to celebrate Halloween, Myriad held a chili…

On Sunday, October 21, 2012 Dr. Matthew McKinley spoke about the importance of hereditary colorectal cancer at the American College of…

A group of Myriad employees attended the Annual Huntsman Cancer Foundation Gala and Survivorship Celebration last Thursday evening at the Grand…

Myriad Genetics is being featured in the November edition of Forbes Magazine! Read the article online HERE and grab a copy…

On Friday, October 19th representatives from Myriad had the distinct pleasure of attending the Red Ball in Manhattan, New York. The…

On September 28th, 2012 Myriad partnered with Living Beyond Breast Cancer (LBBC) to educate breast cancer survivors at the Annual LBBC…

This past Saturday, October 13th, 2012, Myriad employees took to the pavement in the annual American Cancer Society’s Making Strides Against…

We would like to take a few Mondays each month to introduce you to some of our shining star employees here…

This BRCA2 positive patient has had a mastectomy and prostatectomy. Yes, you read that correctly. Meet Robert, a male HBOC carrier…

Leslie had everything planned for her upcoming Thanksgiving feast. Her Christmas shopping lists were in order, and she was ready to…

Today was an inspirational day here at Myriad.  We had two amazing speakers on hand to discuss their organizations, David Barley,…

September 26, 2012 is National Previvor Day. At Myriad, we believe knowledge is power, and Previvors embody this sentiment. A Previvor…

In 2010, Congress passed a resolution declaring the last week of September as National Hereditary Breast and Ovarian Cancer (HBOC) Week…

More than 20,000 women are diagnosed with ovarian cancer each year, and approximately 15,000 women die from the disease each year.…